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Purpose: This study was designed to evaluate the levels of Interleukin-6 (IL6) and Hepcidin prohormone (Hep) in the
serum and aqueous humor of patients with primary open-angle glaucoma (POAG), as well as those with senile cataract
as a control group.
Methods: Levels of IL6 and Hep were measured by enzyme-linked immunosorbent assay (ELISA) methods in serum and
aqueous humor aspirates taken from 45 patients (POAG=20, Control=25) during anterior segment surgery.
Results: The mean aqueous humor Hep concentration in eyes with POAG was significantly higher than that controls
(34.55±23.01 ng/ml versus 20.82± 24.63 ng/ml, p=0.04). There was no significant difference between the serum Hep
concentration of POAG and the control group (359.46±113.03 ng/ml versus 287.36±130.53 ng/ml, p=0.08). There was
also no significant difference between either serum (6.18±5.22 versus 10.84±3.37, pg/ml p=0.112) or aqueous humor
(4.39±3.06  versus  5.79±2.63,  pg/ml  p=0.14)  IL6  concentrations  of  POAG  and  the  control  groups.  No  significant
correlations were found between aqueous humor and serum Hep and IL6 levels in either POAG or the control groups
(p>0.05).
Conclusions: The aqueous humor Hep level may exist locally and independent from the IL6 increase in patients with
POAG, suggesting that Hep might represent a bridge protein between local inflammation and the consequent loss of retinal
ganglion cells.
Glaucoma  is  a  multifactorial,  progressive  optic
neuropathy with a characteristic loss of retinal ganglion cells
(RGCs) beyond typical age-related baseline loss. It is the
second leading cause of blindness in the word [1-3].
Reactive oxygen species (ROS) play a fundamental role
in the pathophysiology of many diseases, including glaucoma.
The iron-catalyzed formation of ROS is a major player in these
processes. The oxygen radical superoxide is a product in cells
from oxidized reactions in the mitochondria and other redox
reactions  in  cells.  Superoxide  is  detoxified  by  superoxide
dismutase with the resulting formation of hydrogen peroxide,
which in the presence of ferrous iron can form the highly
reactive  and  damaging  hydroxyl  radical.  Clearly,  careful
control of iron availability is central to the maintenance of
normal cell functioning [4].
The  Hepcidin  prohormone  (Hep)  is  a  small  peptide
produced in the liver. Human Hep is produced from an 84
amino acid precursor, including a putative single peptide. Hep
is an important peptide hormone that plays a critical role in
the  regulation  of  iron  efflux  from  numerous  cell  types,
including intestinal cells, macrophages, and hepatocytes. Hep
binds to and induces the degradation of ferroportin, a protein
for iron efflux [5]. Therefore, Hep is responsible for iron
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homeostasis, decreasing iron uptake from the intestine, and
release  from  the  liver  in  conditions  of  iron  overload.
Conversely, Hep syntheses are decreased in iron deficiency,
resulting  in  increased  iron  uptake  from  the  intestine  and
release from liver stores [6].
A recent study found that Hep is expressed in Muller
cells, photoreceptor cells, and retinal pigmented epithelium
(RPE) in an expression pattern similar to that of ferroportin.
The increase in Hep expression correlates with a decrease in
ferroportin expression, as well as an increase in oxidative
stress and apoptosis, as would be expected from an increase
in intracellular iron resulting from decreased iron export [7].
The expression of Hep in the retina points to the local
intraocular regulation of iron metabolism, separate from a
dependence  on  the  circulation  liver-derived  hormone:
circulating Hep would likely be inaccessible to intraocular
tissues due to the presence of blood-ocular barriers [8].
Interleukin-6 (IL6) is a multi-functional cytokine that
regulates  immune  responses,  acute  phase  reactions,  and
hematopoiesis, and may play a central role in host defense
mechanisms. Studies have identified IL6 as a possible inducer
of Hep syntheses [9-11].
Based on the reported literature, the aim of the present
study was to investigate the Hep and IL6 levels in the aqueous
humor  and  serum  of  patients  with  primary  open-angle
glaucoma (POAG) and compare these with senile cataract
patients as a comparative (control) group.
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The study was designed as a prospective case control study
and was performed from August 2008 to July 2009 in the
Nikookari Eye Hospital in Tabriz, Iran.
Twenty patients with POAG (9 females and 11 males)
and  intraocular  surgery  indication,  and  25  age-  and  sex-
matched senile cataract patients without glaucoma (13 males
and 12 females) were included in the study.
Informed consent was taken from all of the patients, and
the study was approved by the ethical committee of Tabriz
University of Medical Science and conducted in accordance
with  the  ethical  principles  outlined  in  the  Declaration  of
Helsinki.
Participants  in  the  POAG  group  were  recruited  from
patients  who  required  trabeculectomy  or
phacotrabeculectomy for uncontrolled or the progression of
glaucomatous  optic  damage  on  maximally  tolerated
medication.  Six  patients  from  this  group  underwent
phacotrabeculectomy  and  14  patients  underwent
trabeculectomy.
Participants were excluded from the study for a history
of  laser  surgery  or  intraocular  surgery,  major  systemic
diseases (diabetes, renal or hepatic disease, hematologic and
autoimmune  disorders,  arteriosclerotic  disease),  and  any
history  of  special  drug  usage  (e.g.,  iron  preparations,
chemotherapeutic agents, vitamins) that could influence the
Hep and IL6 levels.
The intraocular pressure (IOP), measured by Goldmann
applanation tonometry, was 21 mmHg or higher in the POAG
group.  All  patients  had  typical  glaucomatous  optic  disc
damage on fundoscopy and a visual field defect was noted in
all patients with the full threshold or Swedish Interactive
Threshold Algorithm strategy, program 24–2, visual field test
on the Humphrey Field Analyzer.
The cup-to-disc ratio of all patients was ≥0.6(0.72±0.20).
Angles were wide open on gonioscopy. According to the cup-
to-disc  ratio,  glaucoma  patients  were  subdivided  into  the
moderate and severe stage subgroups. In the moderate stage
subgroup, the cup-to-disc ratio was ≤0.7. All patients received
at least two topical antiglaucoma drugs.
All  patients  enrolled  in  the  control  group  had  senile
cataracts with a normal IOP and did not receive any topical
medication.
Aqueous humor samples (≈0.2 ml) were collected at the
beginning of surgery through clear corneal paracentesis, using
a 27 gauge needle on an insulin syringe under an operating
microscope with special care to avoid blood contamination.
Aqueous humor samples were immediately cooled at −70 °C
and protected from light until analysis. Venous blood samples
were also collected in the fasting state, 24 h before surgery.
The samples were centrifuged within 1hr and stored at −70 °C
until analysis was performed.
The Hep and IL6 levels in both serum and aqueous humor
samples were measured by enzyme-linked immunosorbent
assay (ELISA) using the DEMEDITEC GmbH (Lot: RN-
24429;  Kiel-Wellsee,  Germany)  and  Bender  MedSystems
GmbH (Lot: 233737; Vienna, Austria) kits, respectively.
All of the data were entered to the SPSS software package
version 13 for Windows (SPSS Ins, Chicago, IL) for statistical
analysis. Results are expressed as mean±SD, numbers, and
their percent when appropriate. The Mann–Whitney U-test
was used for statistical analyses. Correlation was evaluated by
Spearman's test and p<0.05.was considered significant.
TABLE 1. DEMOGRAPHIC AND BASELINE CHARACTERISTICS OF BOTH STUDY GROUPS.
Variable POAG(a) (n=20) Control(b) (n=25) p-value
Age (years)(c) 71.1±6.3 70.8±6.5 0.97(d)
Sex n (%)
Female 9 (45%) 12 (48%) 0.56(e)
Male 11 (55%) 13 (52%)  
BMI (kg/m2)(f)(c) 25.56±4.26 25.35±4.12 0.52(d)
Intraocular pressure (mm Hg) 25.50±3.73 14.23±1.24 0.04(d)
Medical therapy n (%)    
2 drops(g) 6 (30%) -  
3 drops(h) 6 (30%) -  
4 drops(i) 8 (40%) -  
Cup-to-disc ratio (% of patients) 0.6 (30%) -  
  0.7 (15%) -  
  0.8 (20%) -  
  ≥0.9 (35%) -  
      (a)Primary open-angle glaucoma. (b)Senile cataract patients. (c)Data are expressed as mean±SD (d)Performed by Mann–Whitney
     U  test. (e)Performed by χ2. (f)Body mass index. (g)Timolol + Latanoprost. (h)Timolol + Dorzolamide + Latanoprost. (i)Timolol +
     Dorzolamide + Latanoprost + Brimonidine.
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All  of  the  patients  completed  the  study  and  none  were
excluded. All measurements were performed successfully,
without any failure in determining Hep and IL6 owing to
insufficient sampling or any other complication during the
analyses.  Demographic  and  baseline  characteristics  of  the
patients are shown in Table 1. There were no statistically
significant differences between the two groups in terms of age,
sex, or body mass index (p>0.05 in all cases).
Although the mean aqueous humor Hep concentration in
patients with POAG was significantly higher than in controls
(p=0.04), there was no significant difference in serum Hep
concentration when compared with controls (p=0.08).
No  significant  difference  was  found  in  aqueous  and
serum IL6 concentrations in patients with POAG compared
with controls (p=0.14 and p=0.11, respectively; Table 2).
There were no significant correlations between Hep and
IL6 levels among patients with POAG and the control group
(p>0.05) (Table 3).
Of  20  patients  with  POAG,  only  2  patients  had  IOP
>23 mmHg after surgery with two antiglaucoma drugs; these
cases were considered failed surgical outcomes.
There  were  no  statistically  significant  differences
between the moderate and severe stage glaucoma subgroups
in the aqueous levels of Hep and IL6 (p=0.65 and p=0.94,
respectively), but the serum levels of Hep were higher in
severe stage patients (p=0.01; Table 4).
DISCUSSION
Conventional  glaucoma  therapy  has  been  focusing  on
lowering IOP. Recent studies have suggested that glaucoma
is  caused  by  multiple  factors  that  ultimately  lead  to  the
apoptotic death of retinal ganglion cells and subsequent optic
nerve  atrophy.  Among  these  are  changes  in  the
microcirculation  of  the  optic  nerve  head,  deprivation  of
trophic factors, and the release of neurotoxin agents within the
retina, such as glutamate, nitric oxide, and free radicals [12].
New discoveries of iron metabolism in the eye include
the regulation of glutamate production and secretion [13,14],
glutathione (GSH) synthesis [15], and the activity of hypoxia
inducible factor-1 (HIF-1). HIF-1 has been shown to have
either a clinically or experimentally mediating or contributing
role  in  several  oxygen-dependent  retinal  diseases  such  as
glaucoma  [16-18].  In  the  literature,  there  is  a  wealth  of
evidence  linking  the  oxidation  of  proteins  to  cataract
formation, and iron has a central role in catalyzing free radical
reactions, leading to oxidative damage [19]. Iron catalyzed
reactions have been linked to changes in lens DNA damage
and  cataract  formation  [20,21].  Thus,  we  included  senile
cataract  patients  as  a  comparative  or  control  group  and
TABLE 2. COMPARISON OF THE HEP AND IL6 CONCENTRATIONS IN THE SERUM AND AQUEOUS HUMOR OF THE STUDY GROUPS.
Variables Hep (ng/ml) IL6 (pg/ml)
Study groups POAG(a) (Mean±SD) Control(b) (Mean
±SD)





Serum 359.46±113.03 287.36±130.53 0.08 6.18±5.22 4.39±3.06 0.11
Aqueous
humor
34.55±23.01 20.82±24.63 0.04 10.84±3.37 5.79±2.63 0.14
        (a)Primary open-angle glaucoma. (b)Senile cataract patients. (c)Performed by Mann–Whitney U-test. IL6: Interleukin-6; Hep:
      Hepcidin prohormone.
TABLE 3. CORRELATIONS OF AQUEOUS HUMOR AND SERUM HEP AND IL6 CONCENTRATIONS AMONG STUDY GROUPS.
Correlation٭ p r
Primary open-angle glaucoma (n=20)
Aqueous humor Hep with serum Hep 0. 93 0.022
Aqueous humor Hep with aqueous humor IL6 0.42 −0.194
Aqueous humor IL6 with serum IL6 0.50 0.160
Serum Hep with serum IL6 0.06 −0.432
Controls (n=25)
Aqueous humor Hep with serum Hep 0.06 0.378
Aqueous humor Hep with aqueous humor IL6 0.20 0.263
Aqueous humor IL6 with serum IL6 0.22 −0.254
Serum Hep with serum IL6 0.52 −0.134
      *Performed by Spearman's test. IL6: Interleukin-6; Hep: Hepcidin prohormone.
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cataracts.
Retinal iron levels increase with age in both humans
[22] and rodents [23], and with disease [24]; thus, in this study
we matched the two groups regarding age and excluded all
patients with a history of major systemic disease.
Alterations  in  the  levels  of  proteins  involved  in  iron
metabolism in the neural retina of aging rodents suggest that
deregulation  of  the  iron  metabolism  and  the  resulting
accumulation of iron could be a causative factor in age-related
retinal degeneration [23].
To  the  best  of  our  knowledge,  this  is  the  first  study
evaluating  Hep  levels  in  human  aqueous  humor.  Gnana
Parksam et al. [9] found that Hep is expressed in Müller cells,
photoreceptors, and RPE in an expression pattern similar to
that of ferroportins.
In our study, the concentration of Hep in the aqueous
humor of the POAG group was significantly higher than that
of the control group, but there was no significant increase or
correlation in the serum levels. We do not know whether this
phenomenon has a primary role in glaucomatous optic nerve
damage or is secondary to a cascade of events that begins with
high  IOP  and  then  continues  to  cause  iron  metabolism
deregulation and additive damage in this way.
We also found that serum Hep levels are higher in more
advanced glaucoma patients but, due to the small sample size
of POAG patients, we classified these patients only according
to cup-to-disc ratio. Thus, we must interpret our findings with
caution.
The results of the present study suggest that local Hep
secretions may have a pathogenic role in POAG. Furthermore,
we did not find any correlation between IL6 and Hep levels
either  in  serum  or  in  aqueous  humor,  supporting  the
hypothesis  that  the  mechanism  of  aqueous  humor  Hep
regulation may be independent in serum and aqueous humor
IL6 levels. A larger sample size, as well as new markers for
iron  metabolism,  will  be  of  great  interest  in  terms  of
confirming  our  results.  We  also  need  to  mention  some
limitations of our study, which will guide future studies. It
must be kept in mind that some protein levels may increase in
glaucoma due to disturbance in the aqueous humor outflow.
Another limitation is the effect of antiglaucomatous drugs on
free radical–induced apoptosis, as well as the possible effect
of these drugs on Hep and IL6 levels.
We believe that understanding iron metabolism in the eye
is essential in light of the preponderance of evidence to the
effect  that  deregulation  of  iron  metabolism  occurs  in
neurologic and retinal degeneration, such as in glaucoma.
Unfortunately, very little is known about iron metabolism in
ocular tissues, and the study was a pilot study on a small group;
still, our results indicate that Hep may also play a role in
glaucomatous pathology.
In summary, these results indicate that aqueous humor
Hep  is  higher  in  POAG  patients,  and  future  studies  are
required to confirm the direct etiological role of Hep in the
induction of POAG.
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